| TGA Action ID |
RC-2025-RN-00450-1 |
| Type of Product |
Medical Device |
| Product Name/Description |
AVVIGO + Multi-Modality Guidance System when used with OptiCross 18 Peripheral Imaging Catheter
Product Descriptions: AVVIGO + MOB SYSTEM EU + ROW, AVVIGO + MOB SYSTEM - REFURB EU + ROW, AVVIGO + MOB SYSTEM - ZERO COST EU + RO, AVVIGO + INT SYSTEM EU + ROW, AVVIGO + INT SYSTEM - REFURB EU + ROW Material Numbers: H7492493320C0, H7492493320CR0, H7492493320CZ0, H7492493320I0, H7492493320IR0
GTIN/UDI: 00191506033309, 00191506033316, 00191506033323, 00191506033361 |
| ARTG Number |
391872 |
| Action Type |
Product Correction |
| Action Level |
Hospital |
| Hazard Classification |
Class II |
| Reason for the Action |
Through a previous notification, RC-2024-RN-00786-1, Boston Scientific notified customers of a potential software anomaly that can occur when the AVVIGO+ Multi-Modality Guidance System is connected to an OptiCross 18 Imaging Catheter. When in Live or Record mode, the grid mark overlay on cross-sectional view would not display correctly.
Boston Scientific has developed a software update to correct this anomaly and will contact customers to schedule an update to their AVVIGO+ Multi-Modality Guidance System. |
| Instructions for Customers/Users |
Boston Scientific will contact customers to schedule the software update.
In the meantime, continue to follow the recommendations below, which were previously provided in the RC-2025-RN-00450-1 communication: - Physicians should use the measurement tools available in Review mode only, to take vessel measurements (refer to detailed instructions included within the AVVIGO+ Multi-Modality Guidance System Instructions for Use, IFU). - If measuring using grid mark overlay is preferred, it should only be performed in Review mode. Additionally, a physician can manually adjust the depth settings through the ‘Case Settings’ menu or elect to remove the grid marks from the display at time of use.
Following completion of the software update it will no longer be necessary to follow these recommendations.
This action has been closed out on 06/10/2026 |
| Action Commencement Date |
8/05/2025 |
| Responsible Entity |
|
| Contact Information |
02 8063 8340 - Boston Scientific representative |